Related Experiment Videos
Prenatal and postnatal steroid therapy and child neurodevelopment
Smadar Friedman1, Eric S Shinwell
1Department of Neonatology, Kaplan Medical Center, PO Box 1, Rehovot 76100, Israel. smadar_e@clalit.org.il
Clinics in Perinatology
|August 25, 2004
Summary
Perinatal steroid therapy may harm developing brains in preterm infants. Guidelines recommend limited steroid use to balance lung disease reduction with neurodevelopmental safety.
Area of Science:
- Neonatal care
- Neurodevelopmental research
- Pharmacology
Background:
- Accumulating evidence suggests potential neurotoxic effects of perinatal steroid therapy on immature brains.
- The developing fetal and preterm infant brain is particularly vulnerable to exogenous substances.
Purpose of the Study:
- To review current recommendations and evidence regarding the optimal use of steroids in preterm infants.
- To minimize lung disease while preventing adverse neurodevelopmental outcomes.
Main Methods:
- Review of current clinical guidelines and scientific literature.
- Analysis of the risks and benefits of prenatal and postnatal steroid administration.
Main Results:
- National Institutes of Health (NIH) guidelines recommend a single course of prenatal steroids for imminent preterm delivery.
- American Association of Pediatrics (AAP) guidelines advocate limiting postnatal steroid therapy to specific cases after the first week of life.
Conclusions:
- Careful consideration and limitation of steroid therapy are crucial in high-risk neonates.
- Balancing the benefits for lung disease with potential neurodevelopmental risks is paramount.